Search Results

There are 24896 results for: content related to: Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases

  1. Rituximab in Severe Pemphigus

    Annals of the New York Academy of Sciences

    Volume 1173, Issue 1, September 2009, Pages: 683–691, Enno Schmidt, Matthias Goebeler and Detlef Zillikens

    Version of Record online : 1 SEP 2009, DOI: 10.1111/j.1749-6632.2009.04744.x

  2. Efficacy and safety of rituximab treatment in Indian pemphigus patients

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 1, January 2013, Pages: e17–e23, A.J. Kanwar, D. Tsuruta, K. Vinay, H. Koga, N. Ishii, T. Dainichi and T. Hashimoto

    Version of Record online : 17 DEC 2011, DOI: 10.1111/j.1468-3083.2011.04391.x

  3. Low-dose rituximab is effective in pemphigus

    British Journal of Dermatology

    Volume 166, Issue 2, February 2012, Pages: 405–412, B. Horváth, J. Huizinga, H.H. Pas, A.B. Mulder and M.F. Jonkman

    Version of Record online : 9 JAN 2012, DOI: 10.1111/j.1365-2133.2011.10663.x

  4. Urban legends: pemphigus vulgaris

    Oral Diseases

    Volume 18, Issue 5, July 2012, Pages: 442–458, N Cirillo, E Cozzani, M Carrozzo and SA Grando

    Version of Record online : 15 FEB 2012, DOI: 10.1111/j.1601-0825.2011.01899.x

    Corrected by:

    Erratum: Erratum

    Vol. 18, Issue 6, 624, Version of Record online: 7 AUG 2012

  5. An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 777–782, K.T. Amber and M. Hertl

    Version of Record online : 3 SEP 2014, DOI: 10.1111/jdv.12678

  6. Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients

    British Journal of Dermatology

    Volume 165, Issue 3, September 2011, Pages: 646–651, J.H. Kim, Y.H. Kim, M.R. Kim and S.-C. Kim

    Version of Record online : 28 AUG 2011, DOI: 10.1111/j.1365-2133.2011.10411.x

  7. You have free access to this content
    Empfehlungen für den Einsatz von Rituximab (anti-CD20-Antikörper) bei bullösen Autoimmundermatosen

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 6, Issue 5, May 2008, Page: no, Michael Hertl, Detlef Zillikens, Luca Borradori, Leena Bruckner-Tuderman, Harald Burckhard, Rüdiger Eming, Andreas Engert, Matthias Goebeler, Silke Hofmann, Nicolas Hunzelmann, Franz Karlhofer, Ocko Kautz, Undine Lippert, Andrea Niedermeier, Martin Nitschke, Martin Pfütze, Marcel Reiser, Christian Rose, Enno Schmidt, Iakov Shimanovich, Michael Sticherling and Sonja Wolff-Franke

    Version of Record online : 25 APR 2008, DOI: 10.1111/j.1610-0387.2007.06602_supp.x

  8. Rituximab: Applications in dermatology

    International Journal of Dermatology

    Volume 45, Issue 10, October 2006, Pages: 1143–1155, Mitra M. Fatourechi, Rokea A. El-Azhary and Lawrence E. Gibson

    Version of Record online : 11 OCT 2006, DOI: 10.1111/j.1365-4632.2006.03007.x

  9. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris

    Internal Medicine Journal

    Volume 45, Issue 3, March 2015, Pages: 284–292, S. Ojaimi, K. O'Connor, M. W. Lin, M. Schifter and D. A. Fulcher

    Version of Record online : 3 MAR 2015, DOI: 10.1111/imj.12674

  10. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

    British Journal of Dermatology

    Volume 166, Issue 4, April 2012, Pages: 844–852, M. Behzad, C. Möbs, A. Kneisel, M. Möller, J. Hoyer, M. Hertl and R. Eming

    Version of Record online : 27 MAR 2012, DOI: 10.1111/j.1365-2133.2011.10732.x

  11. You have free access to this content
    Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 6, Issue 5, May 2008, Pages: 366–373, Michael Hertl, Detlef Zillikens, Luca Borradori, Leena Bruckner-Tuderman, Harald Burckhard, Rüdiger Eming, Andreas Engert, Matthias Goebeler, Silke Hofmann, Nicolas Hunzelmann, Franz Karlhofer, Ocko Kautz, Undine Lippert, Andrea Niedermeier, Martin Nitschke, Martin Pfütze, Marcel Reiser, Christian Rose, Enno Schmidt, Iakov Shimanovich, Michael Sticherling and Sonja Wolff-Franke

    Version of Record online : 16 JAN 2008, DOI: 10.1111/j.1610-0387.2007.06602.x

  12. Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 2, February 2014, Pages: 186–191, H.H. Cho, S.-P. Jin and J. H. Chung

    Version of Record online : 29 JAN 2013, DOI: 10.1111/jdv.12080

  13. Off-label uses of rituximab in dermatology

    Dermatologic Therapy

    Volume 20, Issue 4, July 2007, Pages: 277–287, David R Carr and Michael P Heffernan

    Version of Record online : 25 OCT 2007, DOI: 10.1111/j.1529-8019.2007.00141.x

  14. Effektivität und Sicherheit von Rituximab beim Pemphigus: Ergebnisse aus dem Deutschen Register für Autoimmunerkrankungen

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue 10, October 2012, Pages: 727–732, Michael Kasperkiewicz, Rüdiger Eming, Melika Behzad, Nicolas Hunzelmann, Michael Meurer, Hendrik Schulze-Koops, Peter von Wussow, Michael Hertl, Detlef Zillikens, Klaus Freivogel, Thomas Dörner and Enno Schmidt

    Version of Record online : 26 SEP 2012, DOI: 10.1111/j.1610-0387.2012.07931_suppl.x

  15. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial

    International Journal of Dermatology

    Volume 52, Issue 7, July 2013, Pages: 862–867, Balighi Kamran, Daneshpazhooh Maryam, Khezri Somayeh, Mahdavi-nia Mostafa, Hajiseyed-javadi Mahsa and Chams-Davatchi Cheyda

    Version of Record online : 23 JUN 2013, DOI: 10.1111/j.1365-4632.2012.5847.x

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 52, Issue 10, 1292, Version of Record online: 23 SEP 2013

  16. You have free access to this content
    Immunoadsorption in Dermatology

    Therapeutic Apheresis and Dialysis

    Volume 16, Issue 4, August 2012, Pages: 311–320, Damian Meyersburg, Enno Schmidt, Michael Kasperkiewicz and Detlef Zillikens

    Version of Record online : 15 MAY 2012, DOI: 10.1111/j.1744-9987.2012.01075.x

  17. Rituximab Therapy for Childhood Pemphigus Vulgaris

    Pediatric Dermatology

    Volume 33, Issue 2, March/April 2016, Pages: e61–e64, Leah Kincaid and Miriam Weinstein

    Version of Record online : 14 JAN 2016, DOI: 10.1111/pde.12744

  18. Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy

    British Journal of Dermatology

    Volume 166, Issue 3, March 2012, Pages: 511–517, R.J. Feldman, W.G. Christen and A.R. Ahmed

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1365-2133.2011.10658.x

  19. Rituximab in refractory autoimmune bullous diseases

    Clinical and Experimental Dermatology

    Volume 31, Issue 4, June 2006, Pages: 503–508, E. Schmidt, N. Hunzelmann, D. Zillikens, E.-B. Bröcker and M. Goebeler

    Version of Record online : 16 MAY 2006, DOI: 10.1111/j.1365-2230.2006.02151.x

  20. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228